dimarts, 18 de novembre del 2014

EPA advisory panel's ruling could disrupt medtech




An EPA advisory panel meeting that began today could disrupt medical device supply chains if the panel upholds the agency's classification of a ubiquitous sterilizer as carcinogenic.






A scientific advisory panel to the EPA is convening today to evalute the environmental watchdog's determination that a common medical device sterilizer, ethylene oxide, is carcinogenic.


If the panel confirms that assessment, medtech companies warn, it could disrupt the supply chain for their lifesaving products.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1uLhzUF

Cap comentari:

Publica un comentari a l'entrada